Large-scale randomised trials - A misguided approach to clinical research

Medical Hypotheses

Volumn 64, Issue 3, 2005, Pages 651-657

  Penston, James ^a  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; CHRONIC DISEASE; CLINICAL RESEARCH; COMMUNITY; DECISION MAKING; DRUG EFFICACY; DRUG INDUSTRY; HUMAN; LONG TERM CARE; MEDICAL INFORMATION; OUTCOMES RESEARCH; POPULATION; PRIORITY JOURNAL; RELIABILITY; SCIENCE; STANDARD; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE;

ARGYROSOMUS REGIUS;

EID: 11144282448     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.09.006     Document Type: Article

References (27)

1. N. Freemantle, and S. Hill Medicalisation, limits to medicine, or never enough money to go around? BMJ 324 2002 864 865
2. J.P. Vandenbroucke Medical journals and the shaping of medical knowledge Lancet 352 1998 2001 2006
3. R.C. McGouran Modern doctoring J Roy Coll Physician Lond 34 2000 582 583
4. B.G. Charlton Fundamental deficiencies in the megatrial methodology Curr Control Trial Cardiovasc Med 2 2001 2 7
5. J.L. Rees Trials, evidence, and the management of patients with psoriasis J Am Acad Dermatol 48 2003 135 143
6. J.R. Hampton Guidelines - for the obedience of fools and the guidance of wise men? Clin Med 3 2003 279 284
7. A.B. Hill Principles of medial statistics: I. The aim of the statistical method Lancet 1 1937 41 43
8. J. Penston Fiction and fantasy in medical research: the large-scale randomised trial 2003 The London Press London
9. R. Taylor Blood pressure and cardiovascular risk in the HOPE study Lancet 359 2002 2117 2118
10. J.M. Bloom Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study Lancet 359 2002 2201
11. D.A. Hume E.C. Mossner Treatise of human nature (1739) 1987 Penguin Books Ltd Middlesex, England [Book I, Part III, Section XIV]
12. A.J. Ayer The central questions of philosophy 1973 Penguin Books Ltd Middlesex, England [Chapter VIII]
13. R.E. Ferner Is concordance the primrose path to health? BMJ 327 2003 821 822
14. D.K. Lewis, J. Robinson, and E. Wilkinson Factors involved in deciding to start preventive treatment: qualitative study of clinician's and lay people's attitudes BMJ 327 2003 841 845
15. G. Elwyn, A. Edwards, and N. Britten Doing prescribing: how doctors can be more effective BMJ 327 2003 864 867
16. A. Edwards Communicating risks BMJ 327 2003 691 692
17. A. Townsend, K. Hunt, and S. Wyke Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use BMJ 327 2003 837 840
18. J. Protheroe, T. Fahey, A.A. Montgomery, and J. Peters The impact of patients' preferences on the treatment of atrial fibrillation: an observational study of patient based decision analysis BMJ 320 2000 1380 1384
19. A.A. Montgomery, J. Harding, and T. Fahey Shared decision making in hypertension: the impact of patient preferences on treatment choice Fam Pract 18 2001 309 313
20. P.N. Trewby, A.V. Reddy, and C.S. Trewby Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs Clin Med 2 2002 527 533
21. I. Heath A wolf in sheep's clothing: a critical look at the ethics of drug taking BMJ 327 2003 856 858
22. H. Thornton Patients' understanding of risk BMJ 327 2003 693 694
23. A. Alaszewski, and T. Horlick-Jones How can doctors communicate information about risk more effectively? BMJ 327 2003 728 731
24. J. Paling Strategies to help patients understand risks BMJ 327 2003 745 748
25. A. Hall The EUROPA trial: definitive evidence at a definitive time: a cardiologist's perspective Br J Cardiol 10 2003 340 341
26. J. Penston EUROPA: definitive evidence at a definitive time Br J Cardiol 10 2003 449
27. A.B. Hill The environment and disease: association or causation? Proc Roy Soc Med 58 1965 295 300